转录因子HHEX调控YAP促进结直肠癌增殖转移的生物学功能和分子机制研究
批准号:
82073201
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
杜鹏
依托单位:
学科分类:
肿瘤复发与转移
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
杜鹏
中文摘要
转录因子HHEX是血液系统发育、分化的关键基因,结直肠癌发生进展中HHEX的作用和机制尚不明确。YAP在结直肠癌中mRNA高表达,与不良预后相关,但结直肠癌中YAP的转录激活机制以及YAP/TEAD转录蛋白复合体的调控机制也尚待深入研究。课题组前期研究发现,结直肠癌中HHEX高表达,促进肠癌细胞增殖、迁移,与肿瘤不良预后相关。结直肠癌中YAP可能是HHEX下游直接靶基因,同时发现HHEX分别与YAP和TEAD4结合形成HHEX-YAP-TEAD4蛋白复合体,可激活YAP/TEAD4的转录活性以及Hippo-YAP通路下游的靶基因,从而促进结直肠癌发生和恶性转化。本项目拟利用基因敲除小鼠模型,通过体外细胞功能与分子机制实验,结合临床组织验证,探讨转录因子HHEX通过调控Hippo-YAP信号通路促进结直肠癌增殖、转移的生物学功能和分子机制,为结直肠癌提供临床诊断分子标记物以及潜在治疗靶点。
英文摘要
Transcription factor HHEX is a key gene for the development and differentiation of the blood system. However, the role and mechanism of HHEX in the development of colorectal cancer is unknown. Overexpression of YAP in colorectal cancer is positively correlated with poor prognosis, but the mechanism of YAP transcriptional activation and the regulation of YAP/TEAD transcription complex in colorectal cancer need to be further studied. Previously, we found that overexpression of HHEX in colorectal cancer might promote the proliferation and migration of cancer cells and was associated with poor prognosis. YAP might be a direct target gene of HHEX in colorectal cancer. Furthermore, it was found that HHEX could combine with YAP and TEAD4 to form the HHEX-YAP-TEAD4 protein complex, which could activate the transcriptional activity of YAP/TEAD4 and target genes of the Hippo-YAP signaling pathway, thereby promoting the progress of colorectal cancer and malignant transformation. By using the knockout mouse model in vitro cell function experiments combined with clinical tissue verification our study intends to explore the biological function and molecular mechanism of HHEX in the development of colorectal cancer providing clinical diagnostic molecular markers and potential therapeutic targets for colorectal cancer.
结直肠癌(Colorectal cancer,CRC)作为严重危害人类健康的第三大癌症,是全球范围内癌症相关死亡的主要原因之一。课题组前期研究发现,结直肠癌中HHEX高表达,促进肠癌细胞增殖,与肿瘤不良预后相关。结直肠癌中YAP可能是HHEX下游直接靶基因,同时发现HHEX分别与YAP和TEAD4结合形成HHEX-YAP-TEAD4蛋白复合体,可激活YAP/TEAD4的转录活性以及Hippo-通路下游的靶基因,从而促进结直肠癌发生和恶性转化。本研究我们首次发现了HHEX-YAP/TEAD4复合体,并解析了该复合体装配的分子机制,证实了HHEX协同YAP/TEAD调控下游靶基因并介导YAP/TEAD的促癌生物学功能;我们首次探讨转录因子HHEX在CRC中的生物学功能,通过体内外细胞功能学、构建繁育肠上皮细胞特异性敲除HHEX的小鼠(villin-Hhex flox/flox)并诱导AOM/DSS肠癌模型证实HHEX可以促进CRC的发生发展;我们首次证实CK2可以通过磷酸化HHEX促进HHEX-YAP/TEAD复合体的形成,并提出将CK2抑制剂和与YAP/TEAD抑制剂联用是潜在的治疗CRC的新型联合用药方案;我们首次确认HHEX高表达与CRC的不良预后密切相关,且HHEX-YAP/TEAD-Hippo调控轴在CRC研究中具有重要的临床价值。
AMBRA1拮抗PP4R1/PP4c复合物促进肠道炎症的生物学功能与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:杜鹏
-
依托单位:
一种小分子热休克蛋白αB-Crystallin肠道抑炎作用及其在炎症性肠病中的调控机制研究
-
批准号:81873547
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2018
-
负责人:杜鹏
-
依托单位:
Notch与Lgr5/Wnt信号通路在溃疡性结肠炎粘膜损伤与再生修复中作用的机制研究
-
批准号:81570474
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:杜鹏
-
依托单位:
国内基金
海外基金